Sundrug Co., Ltd. (SDGCF)
28.18
0.00 (0.00%)
USD |
OTCM |
Sep 23, 16:00
Sundrug Accounts Receivable (Quarterly) : 181.97M for June 30, 2026
Accounts Receivable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Accounts Receivable (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 181.97M |
| March 31, 2026 | 203.22M |
| December 31, 2025 | 209.86M |
| September 30, 2025 | 184.16M |
| June 30, 2025 | 198.30M |
| March 31, 2025 | 200.58M |
| December 31, 2024 | 193.18M |
| September 30, 2024 | 172.52M |
| June 30, 2024 | 160.74M |
| March 31, 2024 | 176.68M |
| December 31, 2023 | 194.03M |
| September 30, 2023 | 152.75M |
| June 30, 2023 | 154.54M |
| March 31, 2023 | 166.95M |
| December 31, 2022 | 188.62M |
| September 30, 2022 | 142.28M |
| June 30, 2022 | 139.64M |
| March 31, 2022 | 157.40M |
| December 31, 2021 | 176.83M |
| September 30, 2021 | 158.19M |
| June 30, 2021 | 167.29M |
| March 31, 2021 | 166.62M |
| December 31, 2020 | 167.79M |
| September 30, 2020 | 129.65M |
| June 30, 2020 | 115.54M |
| Date | Value |
|---|---|
| March 31, 2020 | 137.00M |
| December 31, 2019 | 126.57M |
| September 30, 2019 | 133.39M |
| June 30, 2019 | 99.44M |
| March 31, 2019 | 87.32M |
| December 31, 2018 | 93.82M |
| September 30, 2018 | 78.22M |
| June 30, 2018 | 81.18M |
| March 31, 2018 | 90.59M |
| December 31, 2017 | 85.27M |
| September 30, 2017 | 68.11M |
| June 30, 2017 | 69.39M |
| March 31, 2017 | 67.64M |
| December 31, 2016 | 67.18M |
| September 30, 2016 | 60.34M |
| June 30, 2016 | 58.83M |
| March 31, 2016 | 60.74M |
| December 31, 2015 | 63.04M |
| September 30, 2015 | 54.09M |
| June 30, 2015 | 46.12M |
| March 31, 2015 | 46.00M |
| December 31, 2014 | 46.67M |
| September 30, 2014 | 41.66M |
| June 30, 2014 | 67.85M |
| March 31, 2014 | 92.08M |
Accounts Receivable Definition
Represents change in working capital due to increase or decrease in receivables for the given period.
Accounts Receivable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Receivable (Quarterly) Benchmarks
| TSURUHA Holdings, Inc. | 882.66M |
| Sugi Holdings Co., Ltd. | 515.99M |
| COSMOS Pharmaceutical Corp. | 5.584M |
| MatsukiyoCocokara & Co. | 430.14M |
| Ain Holdings, Inc. | 184.56M |